Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

China · Delayed Price · Currency is CNY

13.87

+0.14 (1.02%)

Nov 5, 2026, 3:00 PM CST

SHA:603896 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	590.94	640.18	705.11	784.35	829.07	767.14
Revenue Growth	-9.93%	-9.21%	-10.10%	-5.39%	8.07%	20.61%
Gross Profit	447.72	503.63	565.1	648.82	699.86	640.76
Operating Income	95.66	86.27	121.36	201.09	238.45	184.3
Net Income	-17.53	18.17	174.44	254.48	277.78	200.83
Earnings Per Share	-0.08	0.09	0.88	1.30	1.43	1.05
EPS Growth	-	-89.77%	-32.31%	-9.09%	36.19%	27.57%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Manufacturing	606.3
Other	22.3
Total	628.6

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	994.57	1,135	1,199	1,504	1,555	807.98
Total Debt	618.22	614.98	588.11	748.4	706.41	106.56
Net Cash (Debt)	376.35	519.57	610.61	755.56	848.31	701.42
Net Cash Growth	-25.73%	-14.91%	-19.18%	-10.93%	20.94%	32.06%
Net Cash Per Share	1.81	2.57	3.08	3.86	4.37	3.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	83.47	228.07	214.97	315.06	341.28	296.7
Capital Expenditures	-199.47	-273.22	-507.07	-414.54	-182.6	-161.63
Free Cash Flow	-116.01	-45.15	-292.1	-99.48	158.68	135.07
Free Cash Flow Growth	-	-	-	-	17.48%	-29.42%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	75.77%	78.67%	80.14%	82.72%	84.41%	83.53%
Operating Margin	16.19%	13.48%	17.21%	25.64%	28.76%	24.02%
Pretax Margin	11.26%	15.95%	24.75%	32.50%	33.53%	26.21%
Profit Margin	-2.97%	2.84%	24.74%	32.45%	33.51%	26.18%
FCF Margin	-19.63%	-7.05%	-41.43%	-12.68%	19.14%	17.61%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.270	0.390	0.440	0.311
Dividend Per Share Growth	-30.77%	-11.36%	41.25%	29.79%
Dividend Yield	1.27%	1.21%	1.11%	0.70%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	211.40	24.11	25.12	28.16	43.99
Forward PE	-	22.02	13.91	20.94	23.38	39.93
P/FCF Ratio	-	-	-	-	49.29	65.41
PS Ratio	4.65	6.00	5.96	8.15	9.43	11.52